Serial Number | 90133236 |
Word Mark | FIBROBODIES |
Filing Date | Monday, August 24, 2020 |
Status | 700 - REGISTERED |
Status Date | Tuesday, March 22, 2022 |
Registration Number | 6674974 |
Registration Date | Tuesday, March 22, 2022 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, August 24, 2021 |
Goods and Services | Pharmaceutical preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and peroral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; Biochemical medicines for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; chemical preparations for pharmaceutical purposes, namely, for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; diagnostic agents for medical purposes; pharmaceutical substances and preparations for the treatment of fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; carrier excipients consisting of compounds that facilitate delivery of pharmaceutical preparations |
Pseudo Mark | FIBRO BODIES |
Goods and Services | Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating fibrotic disease, liver fibrosis, kidney fibrosis, lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease |
Goods and Services | Medical services, namely, in vitro analysis for medical and pharmaceutical use; Medical services, namely, in vitro testing for medical and pharmaceutical use; consultancy and information services provided via the Internet relating to pharmaceutical products |
Goods and Services | Pharmaceutical research services; conducting clinical trials for others relating to pharmaceuticals; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; scientific research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, September 26, 2020 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, September 26, 2020 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, September 26, 2020 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, September 26, 2020 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | LinXis B.V. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 16 - Limited Liability Company |
Address | AMSTERDAM 1081GM NL |
Party Name | LinXis B.V. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | AMSTERDAM 1081GM NL |
Party Name | LinXis B.V. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | AMSTERDAM 1081GM NL |
Event Date | Event Description |
Tuesday, March 22, 2022 | REGISTERED-PRINCIPAL REGISTER |
Friday, February 11, 2022 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
Tuesday, January 18, 2022 | NOTICE OF ALLOWANCE CANCELLED |
Friday, February 11, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Tuesday, January 18, 2022 | TEAS DELETE 1(B) BASIS RECEIVED |
Tuesday, October 19, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, August 24, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, August 24, 2021 | PUBLISHED FOR OPPOSITION |
Wednesday, August 4, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, July 20, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, June 4, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, June 4, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, June 2, 2021 | ASSIGNED TO LIE |
Thursday, March 4, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Sunday, December 27, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Sunday, December 27, 2020 | NON-FINAL ACTION E-MAILED |
Sunday, December 27, 2020 | NON-FINAL ACTION WRITTEN |
Saturday, December 19, 2020 | ASSIGNED TO EXAMINER |
Saturday, September 26, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, August 27, 2020 | NEW APPLICATION ENTERED IN TRAM |